Marcela Moreno Wilches
Latin News Agency for Medicine and Public Health
Medicine in recent years has been moving in search of a personalized treatment approach and based on the search for alternative low molecular and genetic analysis methods.
In an interview with the Journal of Medicine and Public Health (MSP), Dr. Omayra Reyes, oncologist hematologist, highlights the benefit of anti-pd1 treatments in the fight against cancer and highlights the importance and contributions of immunotherapy, which acts by loving the immune system to fight cells · Cancer cells.
The specialist describes these treatments as a breakthrough in oncology, where the introduction of immunotherapies or anti-pd1 they have come to revolutionize oncology in the sense that they have managed to offer patients more years of life than before to contain more limited treatments.
“Basically in the case of immunotherapy, what are the anti-pd1 agents have betrayed a new combination in kidney cancer patients, which has advanced, offering increased survival compared to what was basically the standard treatmentThe oncologist pointed out.
Today, when comparing drugs from years ago with the current ones, it can be shown that it offers patients a 24-month survival in 74 or 75% of patients.
Quality of life and side effects are also much more manageable, as well as toxic effects are observed in clinical studies, while in clinical practice it is observed that the number of patients who tolerate more is increasing. the combination of treatments such as those already approved with checkpoint inhibitors that basically increase survival and keep the medical condition stable.
Inhibitor treatments do not necessarily have to act in combination with other treatments, but can be used in a sequential way to decrease the chances of toxic effects.
Benefit of anti-pd1 inhibitors
Compared to treatments used years ago, checkpoint inhibitors have a much safer side effect profile and the response the patient gets to their medical condition is much more sustainable.
Within the treatment with this type of medication, Dr. Reyes also highlights the tolerability of them, a profile of safe side effects and emphasizes that the response profile they offer, especially increase the overall survival of all cancer patients. who use it.